Leukemia
(UTX-TGR-204) A Multi-Center, Open-Label, Compassionate Use Extension Study of Ublituximab (TG-1101) in Combination with Umbralisib (TGR-1202) for Patients Previously Enrolled in Protocol UTX-TGR-304
- Details
ClinicalTrials.gov ID:
NCT02656303
Diagnosis Type:
CLL
USOR Number:
- Address
4700 E Hale Parkway, Suite 400
Denver, CO 80220
P: (303) 321-0302